Abstrakt: |
A study conducted at Shandong University in China has discovered a class of nonnucleoside reverse transcriptase inhibitors that show promising antiviral activity against HIV-1, including drug-resistant strains. The most potent inhibitor, compound 23h, demonstrated significant activity against challenging double-mutant strains and showed improved resistance profiles compared to current first-line drugs. The study also confirmed that compound 23h targets HIV-1 reverse transcriptase and has good pharmacokinetic properties and safety in vivo. This research suggests that compound 23h has the potential to be an effective antiviral agent for HIV/AIDS treatment. [Extracted from the article] |